Search

Your search keyword '"Wells, Richard A."' showing total 1,756 results

Search Constraints

Start Over You searched for: Author "Wells, Richard A." Remove constraint Author: "Wells, Richard A."
1,756 results on '"Wells, Richard A."'

Search Results

1. Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria

4. Labor Studies and the Political Economy of Trump

5. A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin–Specific Immune Responses and Tuberculosis

6. Similarity of Risk Factors for Musculoskeletal Disorders and Poor Product Quality in Manufacturing

8. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE

9. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies

10. Revised 15-item MDS-specific frailty scale maintains prognostic potential

14. Examining the Influence of a Support Seminar on Pre-Service Teachers' Preparedness for Student Teaching

15. Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

17. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.

19. Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria

20. OVER THE SIDE: A U.S. NAVY AERIAL PHOTOGRAPHER CAPTURED DRAMATIC IMAGES OF AIRCRAFT CARRIER FLIGHT OPERATIONS DURING THE KOREAN WAR

30. The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes

32. Excess Mortality in Ontario During the COVID-19 Pandemic

45. A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

47. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: results of a pilot randomised trial RBC-ENHANCE and a combined analyses with REDDS

Catalog

Books, media, physical & digital resources